Literature DB >> 32021580

Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis.

Andrea Cipriani, Toshi A Furukawa, Georgia Salanti, Anna Chaimani, Lauren Z Atkinson, Yusuke Ogawa, Stefan Leucht, Henricus G Ruhe, Erick H Turner, Julian P T Higgins, Matthias Egger, Nozomi Takeshima, Yu Hayasaka, Hissei Imai, Kiyomi Shinohara, Aran Tajika, John P A Ioannidis, John R Geddes.   

Abstract

(Reprinted with permission from Lancet 2018; 391:1357-66).
Copyright © 2018 by the American Psychiatric Association.

Entities:  

Year:  2018        PMID: 32021580      PMCID: PMC6996085          DOI: 10.1176/appi.focus.16407

Source DB:  PubMed          Journal:  Focus (Am Psychiatr Publ)        ISSN: 1541-4094


  43 in total

1.  Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis.

Authors:  Gustavo C Medeiros; Todd D Gould; William L Prueitt; Julie Nanavati; Michael F Grunebaum; Nuri B Farber; Balwinder Singh; Sudhakar Selvaraj; Rodrigo Machado-Vieira; Eric D Achtyes; Sagar V Parikh; Mark A Frye; Carlos A Zarate; Fernando S Goes
Journal:  Mol Psychiatry       Date:  2022-06-27       Impact factor: 15.992

Review 2.  Defensive and Emotional Behavior Modulation by Serotonin in the Periaqueductal Gray.

Authors:  Priscila Vázquez-León; Abraham Miranda-Páez; Kenji Valencia-Flores; Hugo Sánchez-Castillo
Journal:  Cell Mol Neurobiol       Date:  2022-07-28       Impact factor: 4.231

3.  The Age Limit Does Not Exist: A Pilot Usability Assessment of a SMS-Messaging and Smartwatch-Based Intervention for Older Adults with Depression.

Authors:  Natalie C Benda; George S Alexopoulos; Patricia Marino; Jo Anne Sirey; Dimitris Kiosses; Jessica S Ancker
Journal:  AMIA Annu Symp Proc       Date:  2021-01-25

4.  Accounting for post-randomization variables in meta-analysis: A joint meta-regression approach.

Authors:  Qinshu Lian; Jing Zhang; James S Hodges; Yong Chen; Haitao Chu
Journal:  Biometrics       Date:  2021-09-29       Impact factor: 2.571

Review 5.  The Putative Antidepressant Mechanisms of Probiotic Bacteria: Relevant Genes and Proteins.

Authors:  Elena Poluektova; Roman Yunes; Valery Danilenko
Journal:  Nutrients       Date:  2021-05-10       Impact factor: 5.717

Review 6.  Whole Body Cryotherapy and Hyperbaric Oxygen Treatment: New Biological Treatment of Depression? A Systematic Review.

Authors:  Marek Krzystanek; Monika Romańczyk; Stanisław Surma; Agnieszka Koźmin-Burzyńska
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-21

7.  A Real-World, Prospective, Multicenter, Single-Arm Observational Study of Duloxetine in Patients With Major Depressive Disorder or Generalized Anxiety Disorder.

Authors:  Gyorgy Szekeres; Sandor Rozsa; Peter Dome; Gabor Barsony; Xenia Gonda
Journal:  Front Psychiatry       Date:  2021-06-17       Impact factor: 4.157

8.  Symptom Cluster-Matching Antidepressant Treatment: A Case Series Pilot Study.

Authors:  Sławomir Murawiec; Marek Krzystanek
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-31

9.  Efficacy of hyperbaric oxygen combined with escitalopram in depression and its effect on cognitive function.

Authors:  Kun Mi; Qiang Guo; Bao-Yan Xu; Man Wang; Hao Bi
Journal:  Pak J Med Sci       Date:  2021 Jul-Aug       Impact factor: 1.088

10.  Primary care-based screening and management of depression amongst heavy drinking patients: Interim secondary outcomes of a three-country quasi-experimental study in Latin America.

Authors:  Amy O'Donnell; Bernd Schulte; Jakob Manthey; Christiane Sybille Schmidt; Marina Piazza; Ines Bustamante Chavez; Guillermina Natera; Natalia Bautista Aguilar; Graciela Yazmín Sánchez Hernández; Juliana Mejía-Trujillo; Augusto Pérez-Gómez; Antoni Gual; Hein de Vries; Adriana Solovei; Dasa Kokole; Eileen Kaner; Carolin Kilian; Jurgen Rehm; Peter Anderson; Eva Jané-Llopis
Journal:  PLoS One       Date:  2021-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.